Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 18, 2016
Second Allogeneic Stem Cell Transplantation for Acute Leukemia Using a Chemotherapy-Only Cytoreduction with Clofarabine, Melphalan, and ThiotepaBarbara Spitzer, Miguel-Angel Perales, Nancy A Kernan, et al.
Transplantation and Cellular Therapy|December 19, 2024
Letermovir for Prevention of Recurrent Cytomegalovirus in High-Risk Allogeneic Hematopoietic Cell Transplantation RecipientsGyuri Han, Anat Stern, Yeon Joo Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 30, 2008
Response to pneumococcal (PNCRM7) and haemophilus influenzae conjugate vaccines (HIB) in pediatric and adult recipients of an allogeneic hematopoietic cell transplantation (alloHCT)Mary Pao, Esperanza B Papadopoulos, Joanne Chou, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 31, 2010
Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minoritiesJuliet N Barker, Courtney E Byam, Nancy A Kernan, et al.
Transplantation and Cellular Therapy|October 14, 2020
Letermovir for Prevention of Cytomegalovirus Reactivation in Haploidentical and Mismatched Adult Donor Allogeneic Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease ProphylaxisAndrew Lin, Jessica Flynn, Lauren DeRespiris, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 5, 2019
Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real-world experienceAndrew Lin, Molly Maloy, Yiqi Su, et al.
Bone Marrow Transplantation|April 28, 2022
CD34+ -selected hematopoietic stem cell transplant conditioned with a myeloablative regimen in patients with advanced myelofibrosisMariam T Nawas, Jeong-Ok Lee, Jessica Flynn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 15, 2011
T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignanciesAnn A Jakubowski, Trudy N Small, Nancy A Kernan, et al.
Blood|August 25, 2007
T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulinAnn A Jakubowski, Trudy N Small, James W Young, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 12, 2017
Allogeneic Hematopoietic Stem Cell Transplantation with Myeloablative Conditioning Is Associated with Favorable Outcomes in Mixed Phenotype Acute LeukemiaBartlomiej M Getta, Mikhail Roshal, Junting Zheng, et al.
Pageof 9